The novel biomarkers for assessing clinical benefits of continuous renal replacement therapy in pediatric sepsis: a pilot study

BACKGROUND: Continuous renal replacement therapy (CRRT) has been considered as an adjuvant therapy for sepsis. However, the novel biomarker to evaluate the benefits of CRRT is limited. The aim of this study was to explore the novel biomarkers involved in the impact of CRRT in pediatric sepsis. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yun, Feng, Shuyun, Miao, Huijie, Liu, Tiantian, Shi, Jingyi, Dou, Jiaying, Wang, Chunxia, Zhang, Yucai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847018/
https://www.ncbi.nlm.nih.gov/pubmed/36650427
http://dx.doi.org/10.1186/s12014-023-09392-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847018/
https://www.ncbi.nlm.nih.gov/pubmed/36650427
http://dx.doi.org/10.1186/s12014-023-09392-2

Ejemplares similares